Literature DB >> 12203138

Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation.

P G Middleton1, H Cullup, A M Dickinson, J Norden, G H Jackson, P R A Taylor, J Cavet.   

Abstract

We investigated the role of polymorphism of the vitamin D receptor (VDR) gene in HLA-matched sibling BMT for polymorphisms previously associated with human disease pathology. In intron 8 of the VDR gene, the B and A alleles of the BsmI and ApaI RFLPs were found to associate with reduced aGVHD when present in the patient's genotype. Logistic regression analysis demonstrated that patient VDR genotype, along with previously identified IL-10(-1064) and IFN-gamma genotype to be risk factors for severe acute GVHD. The A allele also associates with increased likelihood of death when present in the donor genotype (AA vs Aa or aa, hazard ratio 2.03, P = 0.0232). In patients who received increased prophylaxis with multi-agent therapy, patients whose graft was from a donor with an AA genotype had a substantially worse survival than patients whose graft was from a donor with a non-AA genotype (hazard ratio 12.93, P < 0.0001). Analysis of VDR genotype in prospective BMT recipients could indicate patients at risk of severe aGVHD. Analysis of VDR genotype in prospective BMT donors may identify individuals who have greater transplant-related mortality, and also allow appropriately restricted use of increased immunosuppressive prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12203138     DOI: 10.1038/sj.bmt.1703629

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  19 in total

Review 1.  Genomic and proteomic analysis of allogeneic hematopoietic cell transplant outcome. Seeking greater understanding the pathogenesis of GVHD and mortality.

Authors:  John A Hansen
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

2.  Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant.

Authors:  Ezgi Karaesmen; Abbas A Rizvi; Leah M Preus; Philip L McCarthy; Marcelo C Pasquini; Kenan Onel; Xiaochun Zhu; Stephen Spellman; Christopher A Haiman; Daniel O Stram; Loreall Pooler; Xin Sheng; Qianqian Zhu; Li Yan; Qian Liu; Qiang Hu; Amy Webb; Guy Brock; Alyssa I Clay-Gilmour; Sebastiano Battaglia; David Tritchler; Song Liu; Theresa Hahn; Lara E Sucheston-Campbell
Journal:  Blood       Date:  2017-08-15       Impact factor: 22.113

3.  Whole-body UVB irradiation during allogeneic hematopoietic cell transplantation is safe and decreases acute graft-versus-host disease.

Authors:  Marina Kreutz; Sigrid Karrer; Petra Hoffmann; Eva Gottfried; Rolf-Markus Szeimies; Joachim Hahn; Matthias Edinger; Michael Landthaler; Reinhard Andreesen; Miriam Merad; Ernst Holler
Journal:  J Invest Dermatol       Date:  2011-08-18       Impact factor: 8.551

Review 4.  Current and future approaches for control of graft-versus-host disease.

Authors:  John Koreth; Joseph H Antin
Journal:  Expert Rev Hematol       Date:  2008-10       Impact factor: 2.929

5.  Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia.

Authors:  Anne M Dickinson; Kim F Pearce; Jean Norden; Stephen G O'Brien; Ernst Holler; Heike Bickeböller; Yesilda Balavarca; Vanderson Rocha; Hans-Jochem Kolb; Ilona Hromadnikova; Petr Sedlacek; Dietger Niederwieser; Ronald Brand; Tapani Ruutu; Jane Apperley; Richard Szydlo; Els Goulmy; Wolfgang Siegert; Theo de Witte; Alois Gratwohl
Journal:  Haematologica       Date:  2010-03-19       Impact factor: 9.941

Review 6.  Vitamin effects on the immune system: vitamins A and D take centre stage.

Authors:  J Rodrigo Mora; Makoto Iwata; Ulrich H von Andrian
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

7.  Vitamin D receptor genotypes and kidney allograft rejection.

Authors:  Negar Azarpira; Mohamad M Sagheb; Bita Geramizadeh; Masumeh Darai
Journal:  Mol Biol Rep       Date:  2009-03-19       Impact factor: 2.316

Review 8.  Advances in predicting acute GVHD.

Authors:  Andrew C Harris; James L M Ferrara; John E Levine
Journal:  Br J Haematol       Date:  2012-12-04       Impact factor: 6.998

Review 9.  The major histocompatibility complex: a model for understanding graft-versus-host disease.

Authors:  Effie W Petersdorf
Journal:  Blood       Date:  2013-07-22       Impact factor: 22.113

10.  Predicting survival using clinical risk scores and non-HLA immunogenetics.

Authors:  Y Balavarca; K Pearce; J Norden; M Collin; G Jackson; E Holler; R Dressel; H-J Kolb; H Greinix; G Socie; A Toubert; V Rocha; E Gluckman; I Hromadnikova; P Sedlacek; D Wolff; U Holtick; A Dickinson; H Bickeböller
Journal:  Bone Marrow Transplant       Date:  2015-07-27       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.